|
1
|
Campochiaro PA: Ocular neovascularization.
J Mol Med (Berl). 91:311–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheung LK and Eaton A: Age-related macular
degeneration. Pharmacotherapy. 33:838–855. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clements JL and Dana R: Inflammatory
corneal neovascularization: Etiopathogenesis. Semin Ophthalmol.
26:235–245. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yeung KK, Yang HJ, Nguyen AL and Weissman
BA: Critical contact lens oxygen transmissibility and tearlens
oxygen tension to preclude corneal neovascularization. Eye Contact
Lens. 44 (Suppl 1):S291–S295. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Voiculescu OB, Voinea LM and Alexandrescu
C: Corneal neovascularization and biological therapy. J Med Life.
8:444–448. 2015.PubMed/NCBI
|
|
6
|
Rahbari NN, Kedrin D, Incio J, Liu H, Ho
WW, Nia HT, Edrich CM, Jung K, Daubriac J, Chen I, et al: Anti-VEGF
therapy induces ECM remodeling and mechanical barriers to therapy
in colorectal cancer liver metastases. Sci Transl Med.
8:360ra1352016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cabral T, Mello LGM, Lima LH, Polido J,
Regatieri CV, Belfort R Jr and Mahajan VB: Retinal and choroidal
angiogenesis: A review of new targets. Int J Retina Vitreous.
3:312017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao Y and Adjei AA: Targeting
angiogenesis in cancer therapy: Moving beyond vascular endothelial
growth factor. Oncologist. 20:660–673. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hellberg C, Ostman A and Heldin CH: PDGF
and vessel maturation. Recent Results Cancer Res. 180:103–114.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lindblom P, Gerhardt H, Liebner S,
Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S,
Landegren U, Nystrom HC, et al: Endothelial PDGF-B retention is
required for proper investment of pericytes in the microvessel
wall. Genes Dev. 17:1835–1840. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dell S, Peters S, Müther P, Kociok N and
Joussen AM: The role of PDGF receptor inhibitors and PI3-kinase
signaling in the pathogenesis of corneal neovascularization. Invest
Ophthalmol Vis Sci. 47:1928–1937. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ricci C and Ferri N: Naturally occurring
PDGF receptor inhibitors with potential anti-atherosclerotic
properties. Vascul Pharmacol. 70:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park DY, Lee J, Kim J, Kim K, Hong S, Han
S, Kubota Y, Augustin HG, Ding L, Kim JW, et al: Plastic roles of
pericytes in the blood-retinal barrier. Nat Commun. 8:152962017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Strittmatter K, Pomeroy H and Marneros AG:
Targeting platelet-derived growth factor receptor β(+) scaffold
formation inhibits choroidal neovascularization. Am J Pathol.
186:1890–1899. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ho CL, Hsu LF, Phyliky RL and Li CY:
Autocrine expression of platelet-derived growth factor B in B cell
chronic lymphocytic leukemia. Acta Haematol. 114:133–140. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koehler NK, Roebbert M, Dehghani K,
Ballmaier M, Claus P, von Hoersten S, Shing M, Odin P, Strehlau J
and Heidenreich F: Up-regulation of platelet-derived growth factor
by peripheral-blood leukocytes during experimental allergic
encephalomyelitis. J Neurosci Res. 86:392–402. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Minardi S, Pandolfi L, Taraballi F, Wang
X, De Rosa E, Mills ZD, Liu X, Ferrari M and Tasciotti E: Enhancing
vascularization through the controlled release of platelet-derived
growth factor-BB. ACS Appl Mater Interfaces. 9:14566–14575. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang H, Yin Y, Li W, Zhao X, Yu Y, Zhu J,
Qin Z, Wang Q, Wang K, Lu W, et al: Over-expression of PDGFR-β
promotes PDGF-induced proliferation, migration, and angiogenesis of
EPCs through PI3K/Akt signaling pathway. PLoS One. 7:e305032012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu P, Li L, Liu G, van Rooijen N, Mukaida
N and Zhang X: Opposite roles of CCR2 and CX3CR1 macrophages in
alkali-induced corneal neovascularization. Cornea. 28:562–569.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rhee I: Diverse macrophages polarization
in tumor microenvironment. Arch Pharm Res. 39:1588–1596. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mayer A, Lee S, Jung F, Grütz G, Lendlein
A and Hiebl B: CD14+ CD163+ IL-10+
monocytes/macrophages: Pro-angiogenic and non pro-inflammatory
isolation, enrichment and long-term secretion profile. Clin
Hemorheol Microcirc. 46:217–223. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marçola M and Rodrigues CE: Endothelial
progenitor cells in tumor angiogenesis: Another brick in the wall.
Stem Cells Int. 2015:8326492015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noskovičová N, Petřek M, Eickelberg O and
Heinzelmann K; From Lung Development and Disease to Clinical
Studies, : Platelet-derived growth factor signaling in the lung.
From lung development and disease to clinical studies. Am J Respir
Cell Mol Biol. 52:263–284. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ostendorf T, Boor P, van Roeyen CR and
Floege J: Platelet-derived growth factors (PDGFs) in glomerular and
tubulointerstitial fibrosis. Kidney Int Suppl (2011). 4:65–69.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jaguin M, Fardel O and Lecureur V:
AhR-dependent secretion of PDGF-BB by human classically activated
macrophages exposed to DEP extracts stimulates lung fibroblast
proliferation. Toxicol Appl Pharmacol. 285:170–178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kryza T, Achard C, Parent C, Marchand-Adam
S, Guillon-Munos A, Iochmann S, Korkmaz B, Respaud R, Courty Y and
Heuzé-Vourc'h N: Angiogenesis stimulated by human
kallikrein-related peptidase 12 acting via a platelet-derived
growth factor B-dependent paracrine pathway. FASEB J. 28:740–751.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang GL and Semenza GL: Desferrioxamine
induces erythropoietin gene expression and hypoxia-inducible factor
1 DNA-binding activity: Implications for models of hypoxia signal
transduction. Blood. 82:3610–3615. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan Y, Hilliard G, Ferguson T and
Millhorn DE: Cobalt inhibits the interaction between
hypoxia-inducible factor-alpha and von Hippel-Lindau protein by
direct binding to hypoxia-inducible factor-alpha. J Biol Chem.
278:15911–15916. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taheem DK, Foyt DA, Loaiza S, Ferreira SA,
Ilic D, Auner HW, Grigoriadis AE, Jell G and Gentleman E:
Differential Regulation of Human Bone Marrow Mesenchymal Stromal
Cell Chondrogenesis by Hypoxia Inducible Factor-1α Hydroxylase
Inhibitors. Stem Cells. 36:1380–1392. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu J, Tang Y, Wu Q, Ji YC, Feng ZF and
Kang FW: HIF-1α facilitates osteocyte-mediated osteoclastogenesis
by activating JAK2/STAT3 pathway in vitro. J Cell Physiol.
234:21182–21192. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahani-Nahayati M, Solali S, Shams Asenjan
K, Movassaghpour Akbari AA, Talebi M, Zadi Heydarabad M,
Baharaghdam S and Farshdousti Hagh M: Promoter methylation status
of survival-related genes in MOLT-4 cells co-cultured with bone
marrow mesenchymal stem cells under hypoxic conditions. Cell J.
20:188–194. 2018.PubMed/NCBI
|
|
33
|
Lolmède K, Durand de Saint Front V,
Galitzky J, Lafontan M and Bouloumié A: Effects of hypoxia on the
expression of proangiogenic factors in differentiated 3T3-F442A
adipocytes. Int J Obes Relat Metab Disord. 27:1187–1195. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu G, Chen L, Cai Q, Wu H, Chen Z, Zhang
X and Lu P: Streptozotocin induced diabetic mice exhibit reduced
experimental choroidal neovascularization but not corneal
neovascularization. Mol Med Rep. 18:4388–4398. 2018.PubMed/NCBI
|
|
35
|
Le YZ, Ash JD, Al-Ubaidi MR, Chen Y, Ma JX
and Anderson RE: Targeted expression of Cre recombinase to cone
photoreceptors in transgenic mice. Mol Vis. 10:1011–1018.
2004.PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Arnaoutova I and Kleinman HK: In vitro
angiogenesis: Endothelial cell tube formation on gelled basement
membrane extract. Nat Protoc. 5:628–635. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bock F, Maruyama K, Regenfuss B, Hos D,
Steven P, Heindl LM and Cursiefen C: Novel anti(lymph)angiogenic
treatment strategies for corneal and ocular surface diseases. Prog
Retin Eye Res. 34:89–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sunderkötter C, Goebeler M,
Schulze-Osthoff K, Bhardwaj R and Sorg C: Macrophage-derived
angiogenesis factors. Pharmacol Ther. 51:195–216. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nielsen SR and Schmid MC: Macrophages as
Key Drivers of cancer progression and metastasis. Mediators
Inflamm. 2017:96247602017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chung AS and Ferrara N: Developmental and
pathological angiogenesis. Annu Rev Cell Dev Biol. 27:563–584.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Carmeliet P: Angiogenesis in health and
disease. Nat Med. 9:653–660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Carmeliet P: Angiogenesis in life, disease
and medicine. Nature. 438:932–936. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rodriguez A, Friman T, Kowanetz M, van
Wieringen T, Gustafsson R and Sundberg C: Phenotypical differences
in connective tissue cells emerging from microvascular pericytes in
response to overexpression of PDGF-B and TGF-β1 in normal skin in
vivo. Am J Pathol. 182:2132–2146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Capitão M and Soares R: Angiogenesis and
inflammation crosstalk in diabetic retinopathy. J Cell Biochem.
117:2443–2453. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sufen G, Xianghong Y, Yongxia C and Qian
P: bFGF and PDGF-BB have a synergistic effect on the proliferation,
migration and VEGF release of endothelial progenitor cells. Cell
Biol Int. 35:545–551. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kovacevic D, Gulotta LV, Ying L, Ehteshami
JR, Deng XH and Rodeo SA: rhPDGF-BB promotes early healing in a rat
rotator cuff repair model. Clin Orthop Relat Res. 473:1644–1654.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bonnet CS and Walsh DA: Osteoarthritis,
angiogenesis and inflammation. Rheumatology (Oxford). 44:7–16.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Park ES, Lee KP, Jung SH, Lee DY, Won KJ,
Yun YP and Kim B: Compound K, an intestinal metabolite of
ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and
migration through G1 arrest and attenuates neointimal hyperplasia
after arterial injury. Atherosclerosis. 228:53–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Maloney SC, Antecka E, Granner T,
Fernandes B, Lim LA, Orellana ME and Burnier MN Jr: Expression of
SIRT1 in choroidal neovascular membranes. Retina. 33:862–866. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Friedlaender GE, Lin S, Solchaga LA, Snel
LB and Lynch SE: The role of recombinant human platelet-derived
growth factor-BB (rhPDGF-BB) in orthopaedic bone repair and
regeneration. Curr Pharm Des. 19:3384–3390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wyler von Ballmoos M, Yang Z, Völzmann J,
Baumgartner I, Kalka C and Di Santo S: Endothelial progenitor cells
induce a phenotype shift in differentiated endothelial cells
towards PDGF/PDGFRβ axis-mediated angiogenesis. PLoS One.
5:e141072010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Miyazaki H, Yoshimatsu Y, Akatsu Y,
Mishima K, Fukayama M, Watabe T and Miyazono K: Expression of
platelet-derived growth factor receptor β is maintained by Prox1 in
lymphatic endothelial cells and is required for tumor
lymphangiogenesis. Cancer Sci. 105:1116–1123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Riabov V, Gudima A, Wang N, Mickley A,
Orekhov A and Kzhyshkowska J: Role of tumor associated macrophages
in tumor angiogenesis and lymphangiogenesis. Front Physiol.
5:752014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Battegay EJ, Rupp J, Iruela-Arispe L, Sage
EH and Pech M: PDGF-BB modulates endothelial proliferation and
angiogenesis in vitro via PDGF beta-receptors. J Cell Biol.
125:917–928. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chaoran Z, Zhirong L and Gezhi X:
Combination of vascular endothelial growth factor
receptor/platelet-derived growth factor receptor inhibition
markedly improves the antiangiogenic efficacy for advanced stage
mouse corneal neovascularization. Graefes Arch Clin Exp Ophthalmol.
249:1493–1501. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shah P, Keppler L and Rutkowski J: A
review of platelet derived growth factor playing pivotal role in
bone regeneration. J Oral Implantol. 40:330–340. 2014. View Article : Google Scholar : PubMed/NCBI
|
